Skip to main content
Jesse Mendelson

Jesse Mendelson

Senior Vice President at Model N, expert in pharmaceutical pricing, government regulation, and revenue compliance.

Sep 9, 2026

1:13
Yeah.
1:13
And, and, um, I'd say the first, I'd say almost 20 years, maybe 18 years it existed, it was just this program that was there, with, it had kind of some minimal growth that was mainly and, um, you know, focused on fairly- federally qualified health centers and getting discounts, and it, it was just this thing that was this operational thing.
1:30
And then you're right, it, it, it exploded with the advent of contract pharmacies in the early 2010s.
1:36
But to your question, the last three to five years, I would say there's two things that really has made this, if not the number one, but the number two topic of conversation among the pharmaceutical community right now.
1:47
The first one is just the explosion of growth when it comes to sales volume and, and, uh, dispensing entities.
1:54
So the number of contract pharmacies only keeps growing.
1:58
The number of contract pharmacies associated with covered entities keeps growing.

16 MINS LATER

18:31
What information do drug makers need, like the core information they need in, in order to manage the compliance part of this effectively?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.